TITLE

A Novel Blood‐Based Colorectal Cancer Diagnostic Technology Using Electrical Detection of Colon Cancer Secreted Protein‐2

AUTHOR(S)
Jeun, Minhong; Lee, Hyo Jeong; Park, Sungwook; Do, Eun‐ju; Choi, Jaewon; Sung, You‐Na; Hong, Seung‐Mo; Kim, Sang‐Yeob; Kim, Dong‐Hee; Kang, Ja Young; Son, Hye‐Nam; Joo, Jinmyoung; Song, Eun Mi; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong‐Hoon; Ye, Byong Duk; Byeon, Jeong‐Sik; Choe, Jaewon; Yang, Suk‐Kyun
PUB. DATE
June 2019
SOURCE
Advanced Science;6/5/2019, Vol. 6 Issue 11, pN.PAG
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Colorectal cancer (CRC) is the second‐leading cause of cancer‐related mortality worldwide, which may be effectively reduced by early screening. Colon cancer secreted protein‐2 (CCSP‐2) is a promising blood marker for CRC. An electric‐field effect colorectal sensor (E‐FECS), an ion‐sensitive field‐effect transistor under dual gate operation with nanostructure is developed, to quantify CCSP‐2 directly from patient blood samples. The sensing performance of the E‐FECS is verified in 7 controls and 7 CRC samples, and it is clinically validated on 30 controls, 30 advanced adenomas, and 81 CRC cases. The concentration of CCSP‐2 is significantly higher in plasma samples from CRC and advanced adenoma compared with controls (both P < 0.001). Sensitivity and specificity for CRC versus controls are 44.4% and 86.7%, respectively (AUC of 0.67), and 43.3% and 86.7%, respectively, for advanced adenomas (AUC of 0.67). CCSP‐2 detects a greater number of CRC cases than carcinoembryonic antigen does (45.6% vs 24.1%), and the combination of the two markers detects an even greater number of cases (53.2%). The E‐FECS system successfully detects CCSP‐2 in a wide range of samples including early stage cancers and advanced adenoma. CCSP‐2 has potential for use as a blood‐based biomarker for CRC.
ACCESSION #
136821915

 

Related Articles

  • Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Ford, A. C.; van Zanten, S. J. O. Veldhuyzen; Rodgers, C. C.; TaIIey, N. J.; Vakil, N. B.; Moayyedi, P. // Gut;Nov2008, Vol. 57 Issue 11, p1545 

    Objective: Colorectal cancer is the second most common cause of cancer death in Europe and North America. Alarm features are used to prioritise access to urgent investigation, but there is little information concerning their utility in the diagnosis of colorectal cancer. Methods: A systematic...

  • Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer. Liu, Xiangxiang; Xu, Tao; Hu, Xiuxiu; Chen, XiaoXiang; Zeng, Kaixuan; Sun, Li; Wang, Shukui // Cancer Management & Research;Apr2018, Vol. 10, p857 

    Purpose: Globally, colorectal cancer (CRC) is one of the most common cancers with high mortality. Although CRC patients in stages I–II are curable after surgical resection, due to the lack of sensitive and specific biomarkers, many patients are in the advanced stages when diagnosed. This...

  • New Developments in Mechanical Enhancement of Colonoscopy: Cuffs, Caps and Rings. Jain, Deepanshu; Sandhu, Naemat; Singhal, Shashideep // Digestion;Jun2016, Vol. 93 Issue 3, p234 

    Background: Colorectal cancer (CRC) is a common cause of cancer-related deaths. Early detection of precursor lesions in the adenoma-carcinoma sequence via colonoscopy can decrease mortality from CRC. Summary: In this review article, we have summarized retrospective studies, prospective single...

  • Individual- and Neighborhood-Level Predictors of Mortality in Florida Colorectal Cancer Patients. Tannenbaum, Stacey L.; Hernandez, Monique; Zheng, D. Dandan; Sussman, Daniel A.; Lee, David J. // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Purpose: We examined individual-level and neighborhood-level predictors of mortality in CRC patients diagnosed in Florida to identify high-risk groups for targeted interventions. Methods: Demographic and clinical data from the Florida Cancer Data System registry (2007–2011) were linked...

  • Cost-Effectiveness of Colorectal Cancer Screening Protocols in Urban Chinese Populations. Huang, Weidong; Liu, Guoxiang; Zhang, Xin; Fu, Wenqi; Zheng, Shu; Wu, Qunhong; Liu, Chaojie; Liu, Yang; Cai, Shanrong; Huang, Yanqin // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists respectively among all malignant tumors in urban populations in China. This study was designed to evaluate the cost-effectiveness of two different CRC screening protocols: faecal occult blood test...

  • Up-Regulation of MicroRNA-145 Associates with Lymph Node Metastasis in Colorectal Cancer. Yuan, Wei; Sui, Chenguang; Liu, Qian; Tang, Wanyan; An, Huaying; Ma, Jie // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Metastasis is the main cause of mortality in patients with solid tumours. Identifying the exact molecules associated with CRC metastasis may be crucial to understand the process, which might also be translated to the diagnosis and treatment of CRC. In this study, we investigate the association...

  • Serum β-glucuronidase as a potential colon cancer marker: a preliminary study. Waszkiewicz, Napoleon; Szajda, Sławomir Dariusz; Konarzewska-Duchnowska, Emilia; Zalewska-Szajda, Beata; Gałązkowski, Robert; Sawko, Anna; Nammous, Halim; Buko, Vyacheslav; Szulc, Agata; Zwierz, Krzysztof; Ładny, Jerzy Robert // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2015, Vol. 69, p436 

    Aim: Colorectal cancer is characterized by high morbidity and mortality in developed countries. The lack of low-cost, easy-to-use screening diagnostic methods is one of the causes of late diagnosis of colorectal cancer. Beta-glucuronidase (GLU) is a lysosomal exoglycosidase involved in...

  • An Automated Intervention With Stepped Increases in Support to Increase Uptake of Colorectal Cancer Screening. Green, Beverly B.; Wang, Ching-Yun; Anderson, Melissa L.; Chubak, Jessica; Meenan, Richard T.; Vernon, Sally W.; Fuller, Sharon // Annals of Internal Medicine;3/5/2013, Vol. 158 Issue 5, p301 

    Background: Screening decreases colorectal cancer (CRC) incidence and mortality, yet almost half of age-eligible patients are not screened at recommended intervals. Objective: To determine whether interventions using electronic health records (EHRs), automated mailings, and stepped increases in...

  • The Impact of Age, Sex and Socioeconomic Deprivation on Outcomes in a Colorectal Cancer Screening Programme. Mansouri, David; McMillan, Donald C.; Grant, Yasmin; Crighton, Emilia M.; Horgan, Paul G. // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: Population-based colorectal cancer screening has been shown to reduce cancer specific mortality and is used across the UK. Despite evidence that older age, male sex and deprivation are associated with an increased incidence of colorectal cancer, uptake of bowel cancer screening...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics